Wednesday, September 30, 2015

Genetic testing company 23andMe to pharmaceutical

Genetic testing company 23andMe plans to extend your business. According to Bloomberg, it is prepared in the next few years the pharmaceutical industry, specifically for the treatment of certain specific diseases.

Tests of the 23andMe process is very simple, just send those tubes with saliva the company, cost us $ 99 you can conduct genetic testing. Final report sent out 6-8 weeks, involving more than 240 health analysis, including history, genealogy, and genetic characteristics. Louis Vuitton (LV) iPhone 6 Plus Case

At present, the company says it has and Pfizer Inc. and Genentech pharmaceutical factory, co-operation. This also means that if 23andMe is getting ready to enter the pharmaceutical industry, and partners in direct competition. Chairman Andy Page said, and pharmaceutical cooperation and will not let their relationship is affected.

CEO Anne Wojcicki said it will accelerate the development of drugs:

"Pharmaceutical companies and customers actually have no direct contact, so they banded together and cooperative manufacturing drugs, to make research and development has a strong background. "

23andMe's pharmacy team will be headed by former leader Richard Scheller of Genentech responsible. In the spring of this year, the company will provide financing for the pharmaceutical sector.

23andMe, started in 2006, has received $ 12.6 million in financing. Wojcicki is also confident about the future:

"Product received FDA approval, we will be able to better develop, also hopes to break through limitations in the future. "

However, based on genetic testing particularities and differences in laws and regulations, in the different countries of the world, 23andMe is also subjected to different treatment.

United Kingdom and Canada: welcome!

October 14, The Globe and Mail pointed out that 23andMe will extend their business to Canada, and United Kingdom companies. In other words, one test, two reports. However, Health Canada has not yet responded to the detection accuracy.

At the end of 14, according to the guardian noted that the 23andMe service stationed in United Kingdom, and have access to scientific ethics Institute (Research Ethics Committee) license.

United Kingdom public relations Minister Catherine Afarian are reluctant to respond to 23andMe's drug business. She said:

"Only a United Kingdom resident has the right to enjoy health analytical services of 23andMe, United States may be able to make concessions, customers allowed to buy not only the raw genetic data analysis. "

United States: Sorry, but ...

23andMe in the United States to eat to a locked door. According to theverge last year of reported, December 2013, United States food drug authority (FDA) stepped in stopped has 23andMe in beauty of detection service, because according to provides, such of gene detection need has corresponding of equipment proved itself of authoritative (and usually this need years of scientific research, and very burn money), but FDA does not full ban its operation, still allows 23andMe for user provides descent report and original gene data.

23andMe has been advertised themselves as patient "to defense the first step," the company, to help users "reduces the risk of serious diseases". Company also claimed in June 14, it had received FDA permission to grant a health report, noting that it allows users to pay attention to their own risk of Bloom syndrome ((a possible cause short stature and of diseases with high incidence of cancer)) potential.

But a New York Times reporter Kira Peikoff noted that her three companies each made a genetic test showed that 23andMe results and two other authoritative bodies have very different from.

It's not over yet. In addition to test the real questionable, the DNA testing also brings some families in trouble. In September, Fast Company reports, a reproductive biologist after the test and found that he had a half-brother or half-sister brother directly lead to divorce.

Gene, ethics, has always been a controversial topic. If the drugs can benefit mankind of genetic testing, which is excellent, but moral privacy issues involved, and how to fit it?

viatheverge&bloomberg

154 votes

HTC One M8

HTC in last year launched One (M7) this paragraph "heavy metal" flagship, attract has many preferences metal texture of fans, follow-up launched has Butterfly s and One Max are is perfunctory, and in March 2014 storage force has long of HTC finally to has once "big outbreak", released has new flagship M8, it has more high of metal accounted for than, double camera and more strong of hardware configuration. Louis Vuitton (LV) iPhone 6 Plus Case

View details of the voting >>

Louis Vuitton (LV) iPhone 6 Plus Case

No comments:

Post a Comment